Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies.
about
DRAL is a p53-responsive gene whose four and a half LIM domain protein product induces apoptosisDNA microarrays on a dendron-modified surface improve significantly the detection of single nucleotide variations in the p53 geneHepatitis C Virus Infection Induces Autophagy as a Prosurvival Mechanism to Alleviate Hepatic ER-Stress ResponseA functional screen identifies miRNAs that inhibit DNA repair and sensitize prostate cancer cells to ionizing radiationAberrant p53 expression in feline vaccine-associated sarcomas and correlation with prognosisMethylation matters5-Fluorouracil induces apoptosis in human colon cancer cell lines with modulation of Bcl-2 family proteinsPersistence of p53 mutations and resistance of keratinocytes to apoptosis are associated with the increased susceptibility of mice lacking the XPC gene to UV carcinogenesis.p53 Immunostaining guided laser capture microdissection (p53-LCM) defines the presence of p53 gene mutations in focal regions of primary prostate cancer positive for p53 protein.Effects of IkappaBalpha and its mutants on NF-kappaB and p53 signaling pathways.Cell cycle control, checkpoint mechanisms, and genotoxic stress.Molecular epidemiology of human cancer risk: gene-environment interactions and p53 mutation spectrum in human lung cancer.Use of a yeast assay to detect functional alterations in p53 in prostate cancer: review and future directions.Anti-cancer effect of Scutellaria baicalensis in combination with cisplatin in human ovarian cancer cell.Progress in cancer gene therapy.Saturated fatty acid metabolism is key link between cell division, cancer, and senescence in cellular and whole organism agingViral carcinogenesis: revelation of molecular mechanisms and etiology of human disease.Soft tissue sarcomas and p53 mutationsDial 9-1-1 for p53: mechanisms of p53 activation by cellular stressCan axillary dissection be avoided by improved molecular biological diagnosis?Lung cancer in never smokers: molecular profiles and therapeutic implications.PIN3 duplication may be partially responsible for TP53 haploinsufficiencyWhat is cancer chemotherapy?Specific-mutational patterns of p53 gene in bladder transitional cell carcinoma among a group of Iraqi patients exposed to war environmental hazards.p53 as a mutagen test in breast cancer.Prediction of P53 mutants (multiple sites) transcriptional activity based on structural (2D&3D) properties.Negative cross-talk between p53 and the glucocorticoid receptor and its role in neuroblastoma cells.Clonality of multifocal urothelial carcinomas: 10 years of molecular genetic studies.Human papillomavirus and p53 mutational status as prognostic factors in head and neck carcinoma.Genetic alterations of multiple tumor suppressors and oncogenes in the carcinogenesis and progression of lung cancer.CMTM3 inhibits human testicular cancer cell growth through inducing cell-cycle arrest and apoptosis.JNK targets p53 ubiquitination and degradation in nonstressed cells.p53 mutations and expression in breast carcinoma in situ.Biomarkers in the molecular pathogenesis of esophageal (Barrett) adenocarcinoma.MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapyConformation-dependent phosphorylation of p53.Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 4: p53 signaling pathway.Synergy of Taxol and radioimmunotherapy with yttrium-90-labeled chimeric L6 antibody: efficacy and toxicity in breast cancer xenografts.Molecular neuro-oncology and the development of targeted therapeutic strategies for brain tumors. Part 5: apoptosis and cell cycle.p53 and the pathogenesis of skin cancer.
P2860
Q24683786-BE8ABC46-5F1F-47C9-BEF4-29B83A3BC8B4Q24810292-DBE89C10-3418-4866-A118-B3138C7BEB64Q26745984-7DFD1C7A-7F5C-4A98-A53C-A108B148B80CQ28260029-FCF810EC-0A2E-41CE-AF03-BFCCA9179E2EQ28282987-EF32488B-CA0F-4B83-906C-197CCAC3FE0FQ28364163-534CD231-5EE2-40F9-B89D-4900342A4010Q28369128-555EEE00-55ED-4F79-B65B-B711ECDD2208Q30827983-1C8E7D7F-F7A3-4855-A633-8B37D21C3478Q31031743-B4817718-0416-4DE3-ACF9-6B889749A418Q33262194-14B8804E-C200-46E5-ACC1-782F8E1C4195Q33608768-EC2D405E-5867-4C23-BC54-DD2DC02C8392Q33643298-550810C1-FD05-4D89-B3A7-68872F413881Q33729053-BD70586F-F889-4BB2-8CF6-4775BE88D403Q33730246-64B8BDEA-8055-4FB6-BE7D-C37187303C0BQ33752288-ADA500CE-A732-4BFC-96C5-8A998FC6CB52Q33819044-396ADC80-E368-4C67-8066-D80E46984DB7Q33846198-FED6ED1B-B11E-4C8D-96C5-3DC32F77CB3BQ33898768-73BCCAB5-6F89-4E87-B2CC-91E62D0E6F1AQ33997846-8026C763-C454-4DCB-90CC-131DAA1CFD2AQ34033291-7AA4E8CB-9F7E-4D85-AFF0-5EEC4AA0F68BQ34177155-A7888218-AFF4-43F5-BD65-5403CBFACFCEQ34252210-E4212415-9BF2-4FE9-A0BD-2B50FD35B098Q34301165-0284DFB4-1A8C-49A3-B041-36EB6D558493Q34396704-4918C67C-6BFE-432D-8575-03F52EB8431BQ34580735-596401F1-47B0-4998-BDD0-362B62C21B71Q34611360-05A459E4-C8BE-4611-B487-36677659B56EQ34677800-0A07A060-66D5-4575-AE97-1B1288991AD0Q34810714-1BD7EF73-928C-4104-9353-CEABE396A65AQ34812060-55AF2A84-223A-46B3-B63F-5E6E3E8A0BA3Q34963574-BF9A8195-FEB7-4E08-93B3-51354BDBB50FQ35106489-915040CF-C3B3-4BD5-977D-928437519757Q35208651-CB63C110-6ABF-462E-89B3-627FE224BC09Q35793421-FA231070-5C14-4D25-9AD8-47AC83B056E8Q35840327-75159369-460D-4967-AA45-3018186FB288Q35848425-470550CA-471C-49AC-A337-D9954F6B2B6CQ36019930-F24BA959-B6DF-4469-9363-427BA636690AQ36066191-959B3804-E928-4526-B758-CA1CC3C004EDQ36108564-3728CB26-B554-4B0B-9D5A-41DFF07EA6C7Q36118431-8D3DA343-5317-405C-A0EA-1362974FB23CQ36149069-C69C317E-789E-4B7F-AE6A-75AACAF98514
P2860
Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies.
description
1996 nî lūn-bûn
@nan
1996 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Structure and function of the ...... cancer therapeutic strategies.
@ast
Structure and function of the ...... cancer therapeutic strategies.
@en
Structure and function of the ...... cancer therapeutic strategies.
@nl
type
label
Structure and function of the ...... cancer therapeutic strategies.
@ast
Structure and function of the ...... cancer therapeutic strategies.
@en
Structure and function of the ...... cancer therapeutic strategies.
@nl
prefLabel
Structure and function of the ...... cancer therapeutic strategies.
@ast
Structure and function of the ...... cancer therapeutic strategies.
@en
Structure and function of the ...... cancer therapeutic strategies.
@nl
P356
P1476
Structure and function of the ...... cancer therapeutic strategies.
@en
P2093
P304
P356
10.1093/JNCI/88.20.1442
P407
P577
1996-10-01T00:00:00Z